Literature DB >> 2606934

Immune reactive proteins as prognostic and clinical markers in malignant cervical neoplasia.

M Radhakrishna Pillai1, P Balaram, N K Hareendran, S Bindu, T Abraham, T K Padmanabhan, M K Nair.   

Abstract

The significance of immune reactive proteins in malignant cervical neoplasia, with particular reference to its prognostic and clinical relevance, was studied in 229 patients. All stages of the disease showed elevated levels of circulating immune complexes (CIC). Patients with stages I/IIA showed elevated levels of IgG, whereas those with stages III and IV showed depressed IgM levels. In the case of IgA, the situation was reversed: patients with advanced disease showed increased levels. Radiotherapy resulted in highly elevated levels of CIC, IgG, and IgA. However, in patients who remained disease-free after radiation treatment, levels of these proteins came down, often falling below pretreatment levels. On the other hand, patients developing recurrent disease showed sustained, high levels of CIC and IgA, with IgG as an isolated case in stage I/IIA. The present study therefore shows that although these increases were non-tumour-specific, patients with persistent elevation of CIC and IgA levels were at much greater risk of developing recurrent disease, thereby proving the merit of these substances as markers in prognosticating the course of disease in malignant cervical neoplasia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606934     DOI: 10.1007/bf00391363

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Serum immunoglobulin levels in humans exposed to therapeutic total-body gamma irradiation.

Authors:  S Chaskes; G C Kingdon; E Balish
Journal:  Radiat Res       Date:  1975-04       Impact factor: 2.841

2.  Circulating immune complexes in patients with breast cancer.

Authors:  K Hoffken; I D Meredith; R A Robins; R W Baldwin; C J Davies; R W Blamey
Journal:  Br Med J       Date:  1977-07-23

3.  Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Nat New Biol       Date:  1972-08-09

Review 4.  Clinical relevance of immune complexes, associated antigen, and antibody in cancer.

Authors:  F A Salinas; K H Wee; H K Silver
Journal:  Contemp Top Immunobiol       Date:  1985

5.  Investigation of circulating immune complexes in patients with breast cancer.

Authors:  M Horváth; B Fekete; P Rahóty
Journal:  Oncology       Date:  1982       Impact factor: 2.935

6.  Immune complexes in ovarian cancer.

Authors:  T A Poulton; M E Crowther; F C Hay; L J Nineham
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

7.  Blocking factors in sera of breast cancer patients.

Authors:  F Tanaka; R H Yonemoto; S R Waldman
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

8.  Inhibition of polymorphonuclear leucocyte locomotion by surface-bound antigen-antibody complexes.

Authors:  C Dahlgren; H Elwing
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

9.  Immune function in malignant cervical neoplasia: a multiparameter analysis.

Authors:  P Balaram; M R Pillai; T K Padmanabhan; T Abraham; N K Hareendran; M K Nair
Journal:  Gynecol Oncol       Date:  1988-11       Impact factor: 5.482

10.  Natural cytotoxicity and serum blocking in malignant cervical neoplasia.

Authors:  M R Pillai; P Balaram; T Abraham; T K Padmanabhan; M K Nair
Journal:  Am J Reprod Immunol Microbiol       Date:  1988-04
View more
  1 in total

1.  Total IgA and IgG in Sera of Patients With Different Primary Malignancies.

Authors:  Terezija M Hrzenjak; Ante Roguljic; Palma Efenberger-Marinculic; Maja Popovic; Zoran Pisl
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.